Abstract
High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is the standard of care for patients with relapsed Hodgkin's lymphoma (HL). However, there is currently little information on the predictors of outcome for patients whose disease recurs after ASCT.
| Original language | English |
|---|---|
| Pages (from-to) | 2430-2434 |
| Number of pages | 5 |
| Journal | Annals of oncology : official journal of the European Society for Medical Oncology / ESMO |
| Volume | 24 |
| DOIs | |
| Publication status | Published - 2013 |
Keywords
- Hodgkin's lymphoma
- autologous stem cell transplantation
- relapse
Fingerprint
Dive into the research topics of 'Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver